Palantir's Latest Plunge Makes it a Stock to Avoid

: PLTR | Palantir Technologies News, Ratings, and Charts

PLTR – Amid macroeconomic uncertainty, it could be wise to dump fundamentally weak stocks to minimize your loss. Despite plunging 49% year-to-date, Palantir’s (PLTR) valuation looks stretched. Also, the company has guided revenue for the second quarter below the consensus estimate. So, it could be wise to avoid the stock now. Read on….

Palantir Technologies Inc. (PLTR) builds software platforms that help organizations integrate their data, decisions, and operations at scale. The company operates through two segments: Commercial and Government. The Commercial segment serves customers working in non-government industries.

The Government segment serves customers in the United States federal government and non-United States governments. It has built three principal software platforms: Palantir Gotham, Palantir Foundry, and Palantir Apollo.

Although PLTR managed to surpass the consensus revenue estimate, it missed the EPS estimate by 50% in the last reported quarter. The company guided $470 million in revenue for the second quarter ending June 30, 2022, below the consensus estimate.

Although PLTR is trying to expand its presence in commercial markets, it still derives a significant chunk of its revenue from government contracts, affecting investors’ sentiments.

Amid surging inflation, the Federal Reserve has maintained an aggressive monetary stance, giving rise to recession fears. This has led to a broad-based sell-off in equities lately. Growth stocks like PLTR were amongst the worst hit as investors shifted their attention toward value stocks.

PLTR has declined 49% in price year-to-date and 62.5% over the past year to close the last trading session at $9.27. It is currently trading 68.3% below its 52-week high of $29.29, which it hit on September 17, 2021.

Here’s what could influence the performance of PLTR in the upcoming months:

Disappointing Financials

PLTR’s adjusted operating margin for the first quarter ended March 31, 2022, came in at 26%, compared to 34% in the year-ago period. The company’s adjusted free cash flow declined 80.2% year-over-year to $29.78 million. 

Also, its adjusted EPS decreased 50% year-over-year to $0.02. Its net cash provided by operating activities declined 69.6% year-over-year to $35.47 million. In addition, its total operating expenses increased 2.7% year-over-year to $391.39 million.

Favorable Analyst Estimates

PLTR’s revenue for fiscal 2022 and 2023 is expected to increase 28.9% and 28.6% year-over-year to $1.99 billion and $2.56 billion, respectively. Its EPS for fiscal 2022 and 2023 is expected to increase 24.8% and 47.7% year-over-year to $0.16 and $0.24, respectively.

Mixed Profitability

PLTR’s trailing-12-month net income margin is negative compared to the 5.17% industry average. Likewise, its trailing-12-month Return on Common Equity is negative compared to the 7.39% industry average. Furthermore, the stock’s 0.52% trailing-12-month asset turnover ratio is 17.9% lower than the industry average of 0.63%.

On the other hand, its 78.16% trailing-12-month gross profit margin is 55.1% higher than the industry average of 50.38%. Also, its 21.21% trailing-12-month levered FCF margin is 128.4% higher than the industry average of 9.28%.

Stretched Valuation

In terms of forward non-GAAP P/E, PLTR’s 57.11x is 238.6% higher than the 16.86x industry average. Likewise, its 1.74x forward non-GAAP PEG is 34.9% higher than the 1.29x industry average. And the stock’s 7.03x forward P/B is 96% higher than the 3.59x industry average.

POWR Ratings Reflect Bleak Prospects

PLTR has an overall D rating, equating to Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight distinct categories. PLTR has an F grade for Value, in sync with its 9.54x forward P/S, which is 254.1% higher than the industry average of 2.69x.

It has a C grade for Quality, consistent with its mixed profitability.

PLTR is ranked #20 out of 24 stocks in the F-rated Software – SAAS industry. Click here to access PLTR’s Growth, Momentum, Stability, and Sentiment ratings.

Bottom Line

PLTR is currently trading below its 100-day and 200-day moving averages of $10.78 and $15.79, respectively, indicating a downtrend.

Although its earnings and revenue are expected to grow in the long term, the stock will likely suffer due to the overall macroeconomic uncertainty and the company’s over-reliance on government contracts. Also, given PLTR’s stretched valuation and poor financials, it could be best avoided now.

How Does SoFi Technologies, Inc. (SOFI) Stack Up Against Its Peers?

PLTR has an overall POWR Rating of D, equating to a Sell rating. Therefore, one might want to consider investing in other Software – SAAS stocks with a B (Buy) rating, such as The Sage Group plc (SGPYY) and MiX Telematics Limited (MIXT).


PLTR shares were unchanged in premarket trading Monday. Year-to-date, PLTR has declined -49.09%, versus a -19.14% rise in the benchmark S&P 500 index during the same period.


About the Author: Dipanjan Banchur


Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
PLTRGet RatingGet RatingGet Rating
SGPYYGet RatingGet RatingGet Rating
MIXTGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

2 Warren Buffett Stocks to Buy and Never Sell

Warren Buffett’s long-term value investing strategy serves as a guide for investors to ensure high returns. With the market volatility becoming more severe after the Fed’s recent interest rate hike, Buffett’s top holdings could be ideal investments for long-term investors. To that end, buying and holding Johnson & Johnson (JNJ) and United Parcel Service (UPS) could be wise. Continue reading…

:  |  News, Ratings, and Charts

3 Stocks That’ll Help You Score Big No Matter What Happens Next

The Fed launched another 75-basis-point rate hike this week and signaled it would keep increasing rates until inflation is under control. The consecutive rate hikes are raising recession concerns. We think fundamentally solid stocks Bristol-Myers (BMY), AT&T (T), and Gilead Sciences (GILD), which have the potential to deliver steady returns despite market uncertainties, could be ideal buys now. Keep reading…

:  |  News, Ratings, and Charts

The Most Sought-After Tech Stock to Buy Right Now

Shares of Microsoft (MSFT) have shed more than 25% year-to-date, with the rising interest rates causing a massive tech sell-off. However, the current low price level allows long-term investors to take a position in the stock to benefit from its solid growth prospects. The company has guided double-digit growth for fiscal 2023. Moreover, MSFT has been increasingly paying dividends, which should help generate a steady income stream. Read more…

:  |  News, Ratings, and Charts

3 Stocks That’ll Help You Score Big No Matter What Happens Next

The Fed launched another 75-basis-point rate hike this week and signaled it would keep increasing rates until inflation is under control. The consecutive rate hikes are raising recession concerns. We think fundamentally solid stocks Bristol-Myers (BMY), AT&T (T), and Gilead Sciences (GILD), which have the potential to deliver steady returns despite market uncertainties, could be ideal buys now. Keep reading…

Read More Stories

More Palantir Technologies (PLTR) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All PLTR News